Drug intelligence / Profile preview

Kangxinning granules

Development stage: Unknown
Lead developer: Inner Mongolia Autonomous Region Pharmaceutical Industry Research Institute
Administration: Oral

Overview

Kangxinning granules is a Traditional Chinese Medicine (TCM) formulation developed by the Inner Mongolia Autonomous Region Pharmaceutical Industry Research Institute for the treatment of cardiovascular conditions. It is specifically indicated for stable exertional angina pectoris and coronary heart disease in patients exhibiting the TCM pattern of Qi deficiency and blood stasis. The therapeutic approach of the granules involves tonifying Qi and activating blood circulation to resolve stasis, which is intended to improve myocardial blood supply and alleviate chest pain. The drug has been investigated in Phase II clinical trials in China, utilizing a randomized, double-blind, placebo-controlled design to evaluate its efficacy and safety profile.

Brand names: Kangxinning granules
Other names: Kangxinning Keli

Beyond the preview

Go deeper on Kangxinning granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kangxinning granules.

Explore the full profile